Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|February 1, 1985
[Continuous ambulatory peritoneal dialysis. 5-year clinical experience]C Fuchs, D Dorn, C Bleckmann, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 28, 1999
[A search for the focus in patients with fever of unknown origin: is positron-emission tomography with F-18-fluorodeoxyglucose helpful?]J Lorenzen, R Buchert, C Bleckmann, et al.
Journal of Nuclear Medicine Technology|May 14, 1999
Quantitative salivary gland scintigraphyS Klutmann, K H Bohuslavizki, S Kröger, et al.
Molecular and Cellular Biology|February 28, 2002
Activating transcription factor 1 and CREB are important for cell survival during early mouse developmentSusanne C Bleckmann, Julie A Blendy, Dorothea Rudolph, et al.
Nuklearmedizin. Nuclear Medicine|April 1, 1999
[Onco-PET: lesion detection by monitor versus standardized film documentation]C Bleckmann, R Buchert, U Schulte, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 5, 2000
Effect of attenuation correction on lesion detectability in FDG PET of breast cancerC Bleckmann, J Dose, K H Bohuslavizki, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 5, 1999
Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancerK H Bohuslavizki, S Klutmann, C Bleckmann, et al.
Development (Cambridge, England)|June 1, 1996
Clustered arrangement of winged helix genes fkh-6 and MFH-1: possible implications for mesoderm developmentK H Kaestner, S C Bleckmann, A P Monaghan, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|December 10, 1999
Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancerK H Bohuslavizki, S Klutmann, W Brenner, et al.
Nuclear Medicine Communications|August 27, 2002
Comparison of fluorodeoxyglucose positron emission tomography and "conventional diagnostic procedures" for the detection of distant metastases in breast cancer patientsJörg Dose, C Bleckmann, S Bachmann, et al.
Pageof 2